The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
The U.S. Food and Drug Administration has approved Journavx (suzetrigine) 50 milligram oral tablets, marking the introduction ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Drug experts Drs. Volkow and McLellan set out a road map to reverse the opioid epidemic in 2016. Find out how we're doing now ...
Two leading drug experts set out a road map to reverse the opioid epidemic in 2016. This is how we've progressed since then.
Women's pain is often misdiagnosed or ignored. But what's being done about it? We asked women and MDs to weigh in on.
In multidisciplinary guidelines issued by the American Society of Regional Anesthesia and Pain Medicine and publishe ...